This is a guest contribution from Tom Hutchinson, Chief Analyst at Cabot Dividend Investor
This crazy pandemic market and economy is unprecedented. While the stock market has had a huge
News
FBL Financial Group Declares Quarterly Dividend
FBL Financial Group, Inc. (NYSE: FFG) today announces that its Board of Directors declared a quarterly cash dividend of $0.50 per share to owners of Class A and Class B common stock. The dividend
US Foods Launches Restaurant Reopening Blueprint, A Guide to Help Operators Prepare to Welcome Their Diners Back
US Foods Holding Corp. (NYSE: USFD) today announced the launch of the company’s latest COVID-19 online operator resource, the US Foods Restaurant Reopening Blueprint. The Restaurant Reopening
Raven Fleet Tracking Gives Ag Retailers a Comprehensive View of Entire Operation
Raven Industries, Inc. (the Company; NASDAQ:RAVN) announced today the release of Slingshot® Fleet Tracking. Backed by Razor Tracking, the platform allows users to wirelessly track the location and
U.S. Department of Energy Selects Fluor Team for Hanford Site Tank Closure Contract
Fluor Corporation (NYSE: FLR) announced today that the U.S. Department of Energy (DOE) selected Hanford Works Restoration, LLC (HWR), a joint venture between a subsidiary of BWX Technologies, Inc
San Juan Basin Royalty Trust Declares Cash Distribution for May 2020
BBVA USA, as Trustee of the San Juan Basin Royalty Trust (the “Trust”) (NYSE:SJT), today declared a monthly cash distribution to the holders of its Units of beneficial interest (the “Unit Holders”)
Agilent PD-L1 Assay Receives FDA Approval for Use as a Companion Diagnostic
Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration has approved the company’s PD-L1 IHC 28-8 pharmDx for expanded use in non-small cell lung cancer
Aptorum Group to Hold Investor Webinar and Q&A Session with President on May 19
Aptorum Group Limited (NASDAQ:APM), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, today announced President and Executive
Lineage Cell Therapeutics to Present at 2020 Solebury Trout Virtual Investor Conference on May 26, 2020
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, announced today that Brian M. Culley
NICE Introduces NEVA@home to Drive Immediate Impact on Service Excellence for Work at Home Employees
NICE (Nasdaq: NICE) today announced the launch of NEVA@home, helping organizations make it easy for their employees to provide continued service excellence even when working remotely. Additionally
PulteGroup’s Built to Honor Program Named 2020 Hearthstone Award Recipient
Today PulteGroup announced that its Built to Honor® program was named a 2020 Hearthstone Award Winner. This is the second time the program has been recognized by Hearthstone after receiving a
Cushman & Wakefield Announces Senior Secured Notes Offering
Cushman & Wakefield plc (NYSE: CWK) (“Cushman & Wakefield”) today announced that its indirect wholly owned subsidiary, Cushman & Wakefield U.S. Borrower, LLC (the “Issuer”), plans to conduct an
Perion Network to Present at the Needham 15th Virtual Technology and Media Conference on Tuesday, May 19
Perion Network Ltd. (NASDAQ:PERI) a global technology company that delivers its Synchronized Digital Branding solution across the three main pillars of digital advertising - ad search, social media
Regis Corporation Announces Successful Amendment to Revolving Credit Facility
Regis Corporation (NYSE: RGS), a leader in the haircare industry, whose primary business is franchising, owning, and operating technology enabled hair salons, announced today that it successfully
QIAGEN Announces Publication of Reasoned Position Statement for Proposed Acquisition by Thermo Fisher and Date for Annual General Meeting
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today the publication of its Reasoned Position Statement in response to the Offer Document published by Thermo Fisher Scientific
VFMCRP and ChemoCentryx announce topline data from phase-II LUMINA-1 trial of CCX140 in Focal Segmental Glomerulosclerosis (FSGS)
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200517005052/en/
Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
ABEO : 2019/2020 revenue up 2.3% / Q4 business significantly impacted by the Covid-19 public health crisis
ABEO, a world leader in sports and leisure equipment, today announces its revenue and order intake for the financial year ended 31 March 2020.
€m Unaudited 2019/2020 2018/2019 Change
NEOVACS : VALIDATION OF THE "RESTARTED" PLAN BY THE PARIS COMMERCIAL COURT
- End of court-ordered receivership proceedings
- Continuation of core research in lupus and allergies
- Creation of a new business investing in BioTechs and MedTechs
- New shareholder (HBR Investment
Spectra7 Announces Listing on the TSX Venture Exchange
Spectra7 Microsystems Inc. (TSX:SEV) (“Spectra7” or the “Company”), a leading provider of high-performance analog semiconductor products for broadband connectivity markets, announced today that the
Albany International Declares Dividend
The Board of Directors of Albany International Corp. (NYSE: AIN) today declared a quarterly dividend of $0.19 per share on the Company’s Class A and Class B Common Stock, payable July 10, 2020, to
Aurinia Pharmaceuticals to Present at 2020 RBC Capital Markets’ Virtual Global Healthcare Conference
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that Peter Greenleaf, President and Chief Executive Officer of Aurinia, will participate in a fireside chat
EPR Properties Announces Conference Call Access to Annual Meeting of Shareholders
EPR Properties (NYSE:EPR) announced today that due to the ongoing public health issues arising from the COVID-19 pandemic and to support the health and well-being of its shareholders, it is
Rubraca® (Rucaparib) Approved in the U.S. as Monotherapy Treatment for Patients with BRCA1/2-Mutant, Metastatic Castration-Resistant Prostate Cancer (mCRPC) Who Have Been Treated with Androgen Receptor-Directed Therapy and a Taxane-Based Chemotherapy
Clovis Oncology, Inc. (NASDAQ: CLVS), announced today that the U.S. Food and Drug Administration (FDA) approved Rubraca® (rucaparib) tablets for the treatment of adult patients with a deleterious B
LA PERLA FASHION HOLDING N.V. : Results for the year ended 31 December 2019
La Perla Fashion Holding N.V.
Registered office: Schiphol Boulevard 127, G4.02, 1118 BG Schiphol, the Netherlands
May 15, 2020
Results for the year ended 31 December 2019
La Perla Fashion Holding
BlackRock Capital Investment Corporation Releases Dividend Election Process Summary for Distribution Payable on July 7, 2020
On May 6, 2020, BlackRock Capital Investment Corporation (the “Company”) announced the declaration by its Board of Directors of a dividend for the second quarter of 2020 at a rate of $0.10 per